# RISK MANAGEMENT FILE (ISO 14971)
**IEC 62304 Compliance - Software Lifecycle**

## 1. PURPOSE
To identify, evaluate, and mitigate potential hazards associated with the use of the HoliLabs platform, ensuring patient safety and data integrity.

## 2. HAZARD ANALYSIS

| ID | Hazard Description | Potential Harm | Initial Risk (Sev x Prob) | Mitigation Strategy | Residual Risk |
| :--- | :--- | :--- | :--- | :--- | :--- |
| **HAZ-01** | Wrong drug interaction alert (CDS Failure) - System fails to alert on known allergy. | Patient receives contraindicated medication (Adverse event). | High | **1.** Require manual clinician review of all prescriptions. **2.** Display clear disclaimer that CDS is adjunctive, not diagnostic. **3.** Automated unit tests for CDS rules engine. | Low |
| **HAZ-02** | AI Scribe transcription error (Hallucination/Omission). | Incorrect clinical fact entered into record, leading to future wrong treatment. | Medium | **1.** Mandatory clinician review UI step before saving SOAP. **2.** Visual diffs or highlight of AI-generated text. **3.** Secondary "Auditor" model validates transcription against clinical rules. | Low |
| **HAZ-03** | Data Breach / Unauthorized Access to PHI. | Privacy violation, psychological harm, regulatory fines. | High | **1.** AES-256 encryption at rest. **2.** RBAC and MFA. **3.** Strict sub-processor agreements. | Low |
| **HAZ-04** | System Downtime during critical patient encounter. | Delay in treatment, lack of access to critical history. | Low | **1.** High-availability cloud deployment. **2.** Offline-mode support for critical read-only views (Progressive Web App). | Acceptable |

## 3. RISK ACCEPTABILITY
After applying the mitigation strategies, all identified risks are reduced to a "Low" or "Acceptable" level. The clinical benefits of structured documentation, error-checking, and AI transcription significantly outweigh the residual risks. The platform is deemed safe for clinical use under its defined intended purpose.